{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:37:46Z","timestamp":1760834266535,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.trim.2022.101776","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:34:26Z","timestamp":1671795266000},"page":"101776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The effect of pre-conditioning immunoglobulin and absolute lymphocyte count on the outcomes of allogeneic hematopoietic cell transplantation"],"prefix":"10.1016","volume":"76","author":[{"given":"Murat","family":"Ka\u00e7maz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semih","family":"Ba\u015fci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcl","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu\u011f\u00e7e Nur","family":"Yi\u011feno\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merih K\u0131z\u0131l","family":"\u00c7akar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Sinan","family":"Dal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fevzi","family":"Altunta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.trim.2022.101776_bb0005","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2010.491","article-title":"Hematopoietic stem cell transplantation: a global perspective","volume":"303","author":"Gratwohl","year":"2010","journal-title":"JAMA."},{"issue":"6","key":"10.1016\/j.trim.2022.101776_bb0010","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/bmt.2017.34","article-title":"Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report","volume":"52","author":"Passweg","year":"2017","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.trim.2022.101776_bb0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1703819","article-title":"European Group for Blood and Marrow Transplantation (EBMT). Accreditation committee. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey","volume":"30","author":"Gratwohl","year":"2002","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.trim.2022.101776_bb0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczy\u0144ski","year":"2020","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.trim.2022.101776_bb0025","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbmt.2011.08.018","article-title":"Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation","volume":"18","author":"Jacobson","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.trim.2022.101776_bb0030","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.bbmt.2012.06.005","article-title":"Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation","volume":"18","author":"Kanda","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"issue":"14","key":"10.1016\/j.trim.2022.101776_bb0035","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1158\/1078-0432.CCR-14-3374","article-title":"Immune recovery after allogeneic hematopoietic stem cell transplantation following flu-TBI versus TLI-ATG conditioning","volume":"21","author":"Hannon","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.trim.2022.101776_bb0040","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","article-title":"Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation","volume":"97","author":"Storek","year":"2001","journal-title":"Blood."},{"issue":"19","key":"10.1016\/j.trim.2022.101776_bb0045","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood-2009-12-234096","article-title":"Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update","volume":"115","author":"Seggewiss","year":"2010","journal-title":"Blood."},{"issue":"1 Suppl","key":"10.1016\/j.trim.2022.101776_bb0050","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.bbmt.2009.10.003","article-title":"Immune reconstitution: how it should work, what\u2019s broken, and why it matters","volume":"16","author":"Gress","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"issue":"2 Suppl 1","key":"10.1016\/j.trim.2022.101776_bb0055","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.tmrv.2007.01.004","article-title":"IVIG hematology and neurology expert panels. Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions","volume":"21","author":"Robinson","year":"2007","journal-title":"Transfus. Med. Rev."},{"issue":"1","key":"10.1016\/j.trim.2022.101776_bb0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-106-1-12","article-title":"Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation","volume":"106","author":"Winston","year":"1987","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"10.1016\/j.trim.2022.101776_bb0065","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJM199009133231103","article-title":"Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation","volume":"323","author":"Sullivan","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.trim.2022.101776_bb0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-139-1-200307010-00007","article-title":"Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial","volume":"139","author":"Cordonnier","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.trim.2022.101776_bb0075","article-title":"Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation","volume":"4","author":"Raanani","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.trim.2022.101776_bb0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.bmt.1705892","article-title":"Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival","volume":"41","author":"Norlin","year":"2008","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"10.1016\/j.trim.2022.101776_bb0085","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant."},{"issue":"9","key":"10.1016\/j.trim.2022.101776_bb0090","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00277-016-2711-1","article-title":"Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016","volume":"95","author":"Ullmann","year":"2016","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.trim.2022.101776_bb0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2022.101776_bb0100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.idc.2019.02.011","article-title":"Bacterial infections in the stem cell transplant recipient and hematologic malignancy patient","volume":"33","author":"Misch","year":"2019","journal-title":"Infect. Dis. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.trim.2022.101776_bb0105","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/ejh.13686","article-title":"Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations","volume":"107","author":"Lacombe","year":"2021","journal-title":"Eur. J. Haematol."},{"issue":"20","key":"10.1016\/j.trim.2022.101776_bb0110","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.trim.2022.101776_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2013.09.004","article-title":"Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review","volume":"342","author":"Ariza-Heredia","year":"2014","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.trim.2022.101776_bb0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/bmt.2008.435","article-title":"Prophylactic i.v. Igs in patients with a high risk for CMV after Allo-SCT","volume":"44","author":"Schmidt-Hieber","year":"2009","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.trim.2022.101776_bb0125","first-page":"273","article-title":"Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis","volume":"12","author":"Bass","year":"1993","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.trim.2022.101776_bb0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1399-0012.1994.tb00935.x","article-title":"Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis","volume":"8","author":"Glowacki","year":"1994","journal-title":"Clin. Transpl."},{"issue":"10","key":"10.1016\/j.trim.2022.101776_bb0135","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.transproceed.2011.08.104","article-title":"Immunoglobulin prophylaxis against cytomegalovirus infection in patients at high risk of infection following allogeneic hematopoietic cell transplantation","volume":"43","author":"Ichihara","year":"2011","journal-title":"Transplant. Proc."},{"issue":"11","key":"10.1016\/j.trim.2022.101776_bb0140","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/bmt.2013.76","article-title":"Incidence and risk factors for hypogammaglobulinemia in pediatric patients following Allo-SCT","volume":"48","author":"Frangoul","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.trim.2022.101776_bb0145","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/bmt.2014.28","article-title":"Risk factors for hypogammaglobulinemia after Allo-SCT","volume":"49","author":"Arai","year":"2014","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.trim.2022.101776_bb0150","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.21873\/anticanres.11483","article-title":"Acute graft versus host disease: a comprehensive review","volume":"37","author":"Nassereddine","year":"2017","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.trim.2022.101776_bb0155","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.trim.2022.101776_bb0160","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3324\/haematol.2020.271445","article-title":"Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation","volume":"107","author":"Massoud","year":"2022","journal-title":"Haematologica."},{"issue":"10","key":"10.1016\/j.trim.2022.101776_bb0165","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.bbmt.2020.06.005","article-title":"Preconditioning absolute lymphocyte count and transplantation outcomes in matched related donor allogeneic hematopoietic stem cell transplantation recipients with reduced-intensity conditioning and antithymocyte globulin treatment","volume":"26","author":"Woo","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.trim.2022.101776_bb0170","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00277-020-04347-1","article-title":"High lymphocyte counts before antithymocyte globulin administration predict acute graft-versus-host disease","volume":"100","author":"Shiratori","year":"2021","journal-title":"Ann. Hematol."},{"issue":"12","key":"10.1016\/j.trim.2022.101776_bb0175","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1007\/s00277-021-04649-y","article-title":"Prevalence of hypogammaglobulinemia and its management with subcutaneous immunoglobulin supplementation in patients after allogeneic hematopoietic stem cell transplantation-a single-center analysis","volume":"100","author":"Karakulska-Prystupiuk","year":"2021","journal-title":"Ann. Hematol."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327422002507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327422002507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:03:33Z","timestamp":1760810613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327422002507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":35,"alternative-id":["S0966327422002507"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2022.101776","relation":{},"ISSN":["0966-3274"],"issn-type":[{"type":"print","value":"0966-3274"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of pre-conditioning immunoglobulin and absolute lymphocyte count on the outcomes of allogeneic hematopoietic cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2022.101776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101776"}}